Education
About Us
Working with TipRanks
Follow Us
Alex C. Levit Insider Profile
4 Followers
Alex C. Levit, CLO, Corp. Sec at Context Therapeutics, holds 81.98K shares in Context Therapeutics (Ticker: CNTX). Most recently, Alex C. Levit Bought $20,000 shares of Context Therapeutics on Jun 10, 2025 for an estimated value of 11.40K.
Alex C. Levit Context Therapeutics (CNTX)CLO, Corp. Sec
Context Therapeutics (CNTX)
CLO, Corp. Sec
Ranked #81,030 out of 102,123 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-41.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CLO, Corp. Sec
Roles that Alex C. Levit holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 12, 2022 - Dec 12, 2023
Return:+1.30%
The most profitable trade made by Alex C. Levit
Alex C. Levit's Trading History
List of latest transactions for each holding click on a transaction to see Alex C. Levit's performance on stock
You May Also Like
Alex C. Levit insider profile FAQ
What is the percentage of profitable transactions made by Alex C. Levit?
The percentage of profitable transactions made by Alex C. Levit is 50%.
What is the average return per transaction made by Alex C. Levit?
The average return per transaction made by Alex C. Levit is -41.90%.
What stocks does Alex C. Levit hold?
Alex C. Levit holds: CNTX stocks.
What was Alex C. Levit’s latest transaction?
Alex C. Levit latest transaction was an Informative Buy of $11.40K.
What was Alex C. Levit's most profitable transaction?
Alex C. Levit’s most profitable transaction was an Informative Buy of CNTX stock on December 12, 2022. The return on the trade was 1.30%.
What is Alex C. Levit's role in Context Therapeutics?
Alex C. Levit's role in Context Therapeutics is CLO, Corp. Sec.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.